news T-cell regulator SLAMF6 may be hindering immunotherapy success 5 March 2020 | By Mandy Parrett (Drug Target Review) A new study conducted in Israel suggests that T cells’ ability to destroy skin cancer increases in the absence of T-cell regulators called SLAMF6.
news Study identifies molecule key in leukaemia treatment resistance 28 August 2019 | By Victoria Rees (Drug Target Review) Researchers have found a molecule, which when deleted, increases leukaemia sensitivity to natural killer cells and is a drug target.
news Scientists develop retina-on-a-chip to study eye diseases 28 August 2019 | By Victoria Rees (Drug Target Review) Combining organoid and organ-on-a-chip technologies, researchers have created a model which will allow them to study eye diseases and treatments for the retina.